Join us at the World Vaccine Congress, a meeting covering scientific and developmental considerations associated with vaccine research. Our teams work across bioanalysis and biomarker-related studies supporting drug development through clinical and preclinical programmes. We will be available to discuss analytical requirements, study considerations and other areas connected to regulated scientific support.
Explore our capabilities:
Attending from Synexa will be:
- Andreia Soares, Head of Scientific Strategies – LinkedIn
- Matt Goodwin, Business Development Director – LinkedIn
To set up a meeting with us at the event, connect with our team on LinkedIn or write to us at contactus@synexagroup.com.
